Phase III Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
To investigate the efficacy and safety of FK506 ophthalmic suspension on eye symptoms in patients with vernal keratoconjunctivitis
Epistemonikos ID: 7189fdfd274da6c603293725dca2dd8222c78c1b
First added on: May 04, 2024